Book Launch: 'The Imposter Phenomenon, why you feel like a fraud and what to do about it' is out now
Research indicates that 70-80% of people may experience imposter “syndrome” at some point. Celebrities such as Michelle Obama, Sheryl Sandberg and Tom Hanks have all spoken about their imposter feelings and even Einstein described himself as an “involuntary swindler”.
Owlstone Medical wins up to $49.1 million award from ARPA-H to develop at-home multi-cancer-early detection tests
Goal of POSEIDON is to enable accurate, low-cost, accessible cancer screening for all AmericansProgram to deliver first-in-class synthetic-sensor based MCED test for Stage I detection of 30+ solid tumorsOwlstone to work in partnership with the MassachuUnconscious bias: the silent hiring mistake you can’t afford
At a talk I gave to HR Directors in Cambridge, the overwhelming consensus was that far too many new hires don’t work out. If that doesn’t surprise you, you’ve probably been stung in the past. So what can we do to get it right first time?
Guardtech open partnership with Dry Air to offer game-changing dry room facility installations for Battery industry and beyond
Suffolk-based cleanroom construction specialists the Guardtech Group are set to combine their envelope knowhow with Dry Air’s groundbreaking sealing techniques and HVAC expertise
The 15-year warning: Why we need to measure lung decline in traffic jams, not clinic waiting rooms
Insights from Bipin Patel, CEO & Founder
Reactive to predictive: potential of lung age for chronic disease management
Insights from Bipin Patel, CEO & Founder
Russ Farn joins eg technology’s Board of Directors
eg technology is pleased to announce the promotion of Russ Farn to the position of Director.
Five leading life science organisations collaborate on inaugural London Bio-Innovation Week
ELRIG, Life Science Integrates, Life Science Nation, One Nucleus and SLAS will provide delegates with the opportunity for cross-event partnering during London BBio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe
Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using Droplet Digital™ PCR (ddPCR™) for Clinical Testing of Critical Oncology Biomarkers
CJ & L Consultancy to launch ‘Rent an eQMS’ – A ready-to-use Compliance Solution on 1st November 2025
Start-ups and small businesses can now access a fully functioning Electronic Quality Management System (eQMS) without the heavy investment of building one in-house. Designed to meet ISO 9001, 13485, 27001, and 45001, our eQMS is adaptable, secure, and available immediately — so you can stay compliant and audit-ready from day one.
Leading Hospital charity in East of England praised for investing early on in promising medical professionals’ careers – helping to bring breakthroughs and change in patient care and treatments
Leading hospital charity Addenbrooke's Charitable Trust (ACT) this year celebrates its 30th anniversary - with its supporters donating more than £150 million towards supporting innovation in patient care. One area the charity is able to invest in is research and fellowships - investing in promising medical professionals early in their careers. At this year's John Addenbrooke Lecture, Roland…
Prizes for team behind game-changing multi-omics method to decode gene regulation
Babraham Institute researchers have developed a new multi-omics method enabling the profiling of multiple histone modifications and gene expression in single cells. Lead researchers, Peter Rugg-Gunn and Yang Wang, received the Top Rising Star award by BioCentury Grand Rounds in recognition of the outstanding translational potential of the scMTR-seq method.
Tagomics publishes a new approach to genome-wide epigenomic profiling
Study published in ‘Cell Reports Methods’ demonstrates the strength of Tagomics’ platform for epigenomic biomarker discovery and applications in liquid biopsyActivace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensiveHow to solve in-building connectivity issues
Solve in-building wireless challenges without the long timelines.Wilson Connectivity’s Hybrid DAS combines proven amplifier technology with fibre-optic reach, enabling rapid deployment for buildings from 100k to 500k sq ft.
The results:
Building bridges at the Oxford Med-Tech Fair: EFEC’s UK–China life sciences vision
EFEC is laying the foundations of a UK–China Life Sciences Innovation Hub to connect innovators, investors and UK partners.
Guardtech support staff member’s epic trek for cancer charity close to the business’ heart
The Haverhill cleanroom construction specialists donated £500 to Sarcoma UK to support their IT & Systems Manager Elliott Sheppard’s 25km trek in honour of his daughter Isobel
Reimagining COPD care for 450 million people: A global mission at scale
A global epidemic
Miebach Consulting doubles footprint on Abingdon Science Park
Bespoke facilities within The Science Quadrant offer additional capacity as part of ongoing growth
Universal drug target potential in scaffolding cells found across the body
Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go ‘rogue’ in many different diseases affecting multiple organs – from acne and psoriasis, to rheumatoid arthritis and inflammatory bowel disease.
Co-development agreement with US insulin pump device company for AT278 and sale of royalty and technology access fees for up to $11 million
This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").
Invent: Life Sciences podcast - make way for advanced therapies – why manufacturing could be coming to a hospital near you
Season 3, Episode 6. In our last episode, we explored the manufacturing strategies that will be key to scaling advanced therapies. Now, we turn our focus to the UK, where new regulatory frameworks and regional collaboration are changing how therapies reach patients.
Beyond the inhaler: Why the future of COPD care is digital, continuous, and predictive
Inhalers: life-saving, but not enough
Daiichi Sankyo joins Milner Therapeutics Consortium
Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner.
Wilson Connectivity’s Hybrid DAS
Corporate campuses, schools, and hospitals can’t wait years for wireless coverage. With Wilson Connectivity’s Hybrid DAS, reliable service is live in weeks.
Quantum computing and AI: Synergy or deep tech rivalry?
In this article, IDTechEx explores the fascinating relationship between quantum computing and AI: two supposed tech revolutions that frequently grab the spotlight. Underneath the hype, there exist both technical synergies and competing market forces.